International Assets Investment Management, LLC Inmune Bio, Inc. Transaction History

International Assets Investment Management, LLC

  • $1.06 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 14, 2021
SELL
$9.29 - $19.33 $6,502 - $13,530
-700 Closed
0 $0
Q4 2020

Jan 22, 2021
BUY
$7.51 - $17.22 $5,257 - $12,054
700 New
700 $12.1 Million

Others Institutions Holding INMB

# of Institutions
61
Shares Held
4.66M
Call Options Held
80K
Put Options Held
41.8K
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $96.7M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email